Related Experiment Video
Updated: Jul 10, 2026
09:11
A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
Published on: August 11, 2012
Immune-mediated control of Chlamydia infection
Nadia R Roan1, Michael N Starnbach
1Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, MA 02115, USA.
Cellular Microbiology
|November 6, 2007
Summary
Chlamydia trachomatis infection causes diseases like infertility and blindness. A Chlamydia trachomatis vaccine is needed to prevent infection and its damaging immune responses.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Chlamydia trachomatis infection is a major cause of preventable blindness and infertility.
- Host immune responses to C. trachomatis can control bacterial replication but are often insufficient for clearance.
- Chronic infection can lead to inflammatory cytokine production and tissue pathology.
Purpose of the Study:
- To highlight the limitations of current immune responses in resolving C. trachomatis infections.
- To emphasize the need for a vaccine that induces sterilizing immunity.
- To underscore the importance of avoiding immune-mediated pathology with a vaccine.
Main Methods:
- This study is a review of existing literature on C. trachomatis immunology.
- Analysis of immune effector mechanisms in response to C. trachomatis.
- Evaluation of vaccine strategies for C. trachomatis.
Main Results:
- Immune responses are often insufficient to clear C. trachomatis, leading to chronic inflammation.
- Continued C. trachomatis presence can result in significant tissue damage and disease.
- Existing immune responses may exacerbate pathology.
Conclusions:
- A C. trachomatis vaccine is crucial for reducing infection incidence and sequelae.
- The ideal vaccine must elicit sterilizing immunity.
- Vaccine development should aim to prevent immune-mediated pathology.
Related Concept Videos
01:29Bacterial Phylum Chlamydiae
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
01:18Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
01:40Cell-mediated Immune Responses
Overview
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...